At The Shot Spot, we prioritize safer, more sustainable alternatives for long-term health, which is why we do not offer Phentermine
Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation
This treatments is recommended 2-3 times every 6 months
These include animal products like meat, fish, dairy items, and eggs
As these non-invasive surrogate measures of ICP have not been validated against the gold standard invasive direct measures of ICP, the diagnostic and monitoring capabilities of these non-invasive tests remain uncertain and the established normative values are lacking
Both the naturally-occurring hormone and the medication enhance your bodys appetite and satiety signals in response to eating, while also slowing gastric emptying (the amount of time it takes food to pass through your digestive system) so you feel fuller for longer